CD44 activation in mature B-cell malignancies by a novel recurrent IGH translocation

Blood

Volumn 115, Issue 12, 2010, Pages 2458-2461

  Hu, Xiao Tong ^a,b   Chen, Yun Wen ^a   Liang, Anthony C T ^a   Au, Wing Yan ^a   Wong, Kai Yau ^a   Wan, Thomas S K ^a   Wong, Michelle L Y ^a   Shen, Lijun ^a   Chan, Ka Kui ^a   Guo, Tianhuan ^a   Chu, Kent Man ^a   Tao, Qian ^c   Chim, Chor Sang ^a   Loong, Florence ^a   Choi, William W L ^a   Lu, Liwei ^a   So, Chi Chiu ^a   Chan, Li Chong ^a   Kwong, Yok Lam ^a   Liang, Raymond H S ^a   Srivastava, Gopesh ^a   more..

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ZHEJIANG UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; GREEN FLUORESCENT PROTEIN; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CHROMOSOME 11P; CONTROLLED STUDY; CYTOPLASM; EXON; GENE; GENE OVEREXPRESSION; GENE TRANSLOCATION; GERMINAL CENTER; HUMAN; HUMAN CELL; IGH GENE; INVERSE POLYMERASE CHAIN REACTION; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; RNA TRANSCRIPTION;

EID: 77950549271     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-09-238782     Document Type: Article

References (32)

1. Willis TG, Dyer MJS. The role of immunoglobulin translocation in the pathogenesis of B-cell malignancies. Blood. 2000;96(3):808-822. (Pubitemid 30618048)
2. Davila M, Foster S, Kelsoe G, Yang K. A role for secondary V(D)J recombination in oncogenic chromosomal translocations? Adv Cancer Res. 2001;81:61-92. (Pubitemid 32566013)
3. Küppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 2001;20(40):5580-5594.
4. Dyer MJ. The pathogenetic role of oncogenes deregulated by chromosomal translocation in Bcell malignancies. Int J Hematol. 2003;77(4):315-320.
5. Küppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005;5(4):251-262.
6. Tonegawa S. Somatic generation of antibody diversity. Nature. 1983;302(5909):575-581.
7. Muramatsu M, Revy P, Muto T, et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000;102(5):553-563.
8. Manis JP, Tian M, Alt FW. Mechanism and control of class-switch recombination. Trends Immunol. 2002;23(1):31-39.
9. Soulas-Sprauel P, Rivera-Munoz P, Malivert L, et al. V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining. Oncogene. 2007;26(56):7780-7791.
10. Chaudhuri J, Basu U, Zarrin A, et al. Evolution of the immunoglobulin heavy chain class switch recombination mechanism. Adv Immunol. 2007;94:157-214. (Pubitemid 46856611)
11. Muramatsu M, Sankaranand VS, Anant S, et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem. 1999;274(26):18470- 18476. (Pubitemid 129519249)
12. Okazaki IM, Kotani A, Honjo T. Role of AID in tumorigenesis. Adv Immunol. 2007;94:245-273.
13. Pasqualucci L, Bhagat G, Jankovic M, et al. AID is required for germinal center-derived lymphomagenesis. Nat Genet. 2008;40(1):108-112.
14. Offit K, Chaganti RS. Chromosomal aberrations in non-Hodgkin's lymphoma: biological and clinical correlations. Hematol Oncol Clin North Am. 1991;5(5):853-869.
15. Farinha P, Gascoyne RD. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol. 2005;23(26):6370-6378. (Pubitemid 46218849)
16. Du MQ, Atherton JC. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut. 2006;55(6):886-893.
17. Willis TG, Jadayel DM, Coignet LJ, et al. Rapid molecular cloning of rearrangement of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood. 1997;90(6):2456-2464.
18. Sonoki T, Willis TG, Oscier DG, Karran EL, Siebert R, Dyer MJ. Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR. Leukemia. 2004;18(12):2026-2031. (Pubitemid 40028430)
19. Chen YW, Hu XT, Liang ACT, et al. High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6 deregulating mutations, in gastric lymphoma. Blood. 2006;108(7):2373-2383.
20. Chin M, Herscovitch M, Zhang N, Waxman DJ, Gilmore TD. Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile. Oncogene. 2009;28(20):2100-2111.
21. National Center for Biotechnology Information. Entrez Nucleotide. http://www.ncbi.nlm.nih.gov/nuccore. Accessed February 12, 2002.
22. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signaling regulators. Nat Rev Mol Cell Biol. 2003;4(1):33-45. (Pubitemid 36077255)
23. Ye BH, Chaganti S, Chang CC, et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J. 1995;14(24):6209-6217. (Pubitemid 26007307)
24. Shaffer AL, Rosenwald A, Staudt LM. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol. 2002;2(12):920-932. (Pubitemid 37323213)
25. Lenz G, Nagel I, Siebert R, et al. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med. 2007;204(3):633-643. (Pubitemid 46457085)
26. Stauder R, Eisterer W, Thaler J, Günthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood. 1995;85(10):2885-2899.
27. Shen Y, Iqbal J, Xiao L, et al. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs. BMC Immunol. 2004;5:20. (Pubitemid 41418092)
28. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503-511. (Pubitemid 30082188)
29. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 1987;15(20):8125-8148.
30. Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts. Blood. 1998;92(9):3025-3034. (Pubitemid 28492306)
31. Malgeri U, Baldini L, Perfetti V, et al. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription- polymerase chain reaction analysis of IGH-MMSET fusion transcripts. Cancer Res. 2000;60(15):4058-4061. (Pubitemid 30636584)
32. Chiu RK, Carpenito C, Dougherty ST, Hayes GM, Dougherty GJ. Identification and characterization of CD44RC, a novel alternatively spliced soluble CD44 isoform that can potentiate the hyaluronan binding activity of cell surface CD44. Neoplasia. 1999;1(5):446-452.